<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">clinvest</journal-id><journal-title-group><journal-title xml:lang="ru">Качественная клиническая практика</journal-title><trans-title-group xml:lang="en"><trans-title>Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2588-0519</issn><issn pub-type="epub">2618-8473</issn><publisher><publisher-name>ООО «Издательство ОКИ</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">clinvest-199</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МНЕНИЯ ЭКСПЕРТОВ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>EXPERT OPINIONS</subject></subj-group></article-categories><title-group><article-title>Анализ закупок лекарственных средств для обеспечения оказания медицинской помощи в условиях стационаров</article-title><trans-title-group xml:lang="en"><trans-title>Analysis of drugs procurement to ensure the provision of medical care in hospitals</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Малаев</surname><given-names>М. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Malaev</surname><given-names>M. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н.</p></bio><email xlink:type="simple">formular-mal@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ООО «Центр фармакоэкономических исследований», Московская область</institution><country>Россия</country></aff><aff xml:lang="en"><institution>LLC "Center for Pharmacoeconomics Research", Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>07</day><month>06</month><year>2018</year></pub-date><volume>0</volume><issue>1</issue><fpage>83</fpage><lpage>86</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Малаев М.Г., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Малаев М.Г.</copyright-holder><copyright-holder xml:lang="en">Malaev M.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.clinvest.ru/jour/article/view/199">https://www.clinvest.ru/jour/article/view/199</self-uri><abstract><p>Одной из законодательных нововведений, направленных на сокращение нарушений в сфере госзакупок, является появление новых действующих лиц — «эксперта» и «экспертной организации», т.е. людей, обладающих специальными познаниями, опытом, квалификацией в области науки, техники, искусства или ремесла, необходимых для проведения экспертизы, а также для проведения аудита. Данная работа посвящена возможности проведения независимой экспертизы закупок лекарственных средств для медицинских организаций стационарного типа.</p></abstract><trans-abstract xml:lang="en"><p>One of the legislative innovations aimed to reduce irregularities in public procurement, is the emergence of new actors — an «expert» and «expert organization», i.e. people with special knowledge, experience, expertise in the field of science, technology, art or craft required for the examination, as well as for auditing. Th is work is devoted to the possibility of carrying out an independent examination of drugs procurement for health care organizations is fixed.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>федеральная контрактная система</kwd><kwd>закупки</kwd><kwd>аудит</kwd><kwd>стационар</kwd><kwd>лекарственные средства</kwd><kwd>ФЗ №44</kwd></kwd-group><kwd-group xml:lang="en"><kwd>federal contract system</kwd><kwd>procurement</kwd><kwd>audit</kwd><kwd>hospital</kwd><kwd>drugs</kwd><kwd>Federal Law №44</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
